ghk-cu clinical trial injection human Order (100mg) A Dermatologist's Take on the

BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use

A physician at one clinic who voted yes framed it directly: "As a physician, I have to make sure that I'm keeping patients as safe as possible." Pushing these compounds entirely underground does not accomplish that

What Makes Ours Better

Klicek R et al

BPC-157: More localized, especially in the GI tract and connective tissue TB-500: Broader systemic effects, influencing cell migration and circulation In some cases, both may be considered together (bpc157 and tb500) as complementary, though decisions must be individualized and physician-guided

Cycling Guidelines BPC-157 and TB500: run in 46 week blocks, can extend to 8 weeks for severe injuries